Science Explorer Back to mapMap
Discussion
Topic · Cardiology and Cardiovascular Medicine

Heart Failure Treatment and Management

Heart Failure Treatment and Management is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 50k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, treatment, and management of heart failure, including guidelines, epidemiology, B-type natriuretic peptide testing, cardiovascular disease burden, hospital readmission rates, risk prediction models, and the impact of renal function on outcomes.

  • Heart Failure
  • Guidelines
  • Diagnosis
  • Treatment
  • B-Type Natriuretic Peptide
  • Epidemiology
  • Cardiovascular Disease
  • Hospital Readmission
  • Risk Prediction
  • Renal Function
Research works
50k
fractional, since 1950
In the world top 10%
5k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+25%
the tick is no change
Largest producer
United States
41% of the 10 largest, 2022-now
Heart Failure Treatment and Management

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Heart Failure Treatment and Management research?

By volume, the United States and China publish the most (3.5k and 1.3k works in 2022-now).

By volume, 2022-now

  1. 1 United States 3.5k works
  2. 2 China 1.3k works
  3. 3 Japan 631 works
  4. 4 United Kingdom 584 works
  5. 5 Italy 525 works
  6. 6 Spain 503 works
  7. 7 Germany 459 works
  8. 8 Australia 335 works
  9. 9 Canada 327 works
  10. 10 India 310 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 41.1%China: 15.5%Japan: 7.5%United Kingdom: 6.9%6 others listed: 29.1%41%largest
United States3,474 · 41.1%China1,313 · 15.5%Japan631 · 7.5%United Kingdom584 · 6.9%6 others listed2,459 · 29.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Heart Failure Treatment and Management research?

By volume in 2022-now, Harvard University publishes the most Heart Failure Treatment and Management research, followed by Mayo Clinic and Chinese Academy of Medical Sciences & Peking Union Medical College.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 152 works
  2. 2 Mayo ClinicUnited States 98 works
  3. 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 67 works
  4. 4 United States Department of Veterans AffairsUnited States 60 works
  5. 5 University of TorontoCanada 57 works
  6. 6 Cleveland ClinicUnited States 55 works
  7. 7 Duke UniversityUnited States 54 works
  8. 8 University of CopenhagenDenmark 54 works
  9. 9 Johns Hopkins UniversityUnited States 53 works
  10. 10 Yale UniversityUnited States 48 works

Who are the leading researchers in Heart Failure Treatment and Management?

The most-cited researchers publishing on Heart Failure Treatment and Management include Douglas G. Altman, Christopher J L Murray and Walter Churchill Willett.

  1. 1 Douglas G. Altman United Kingdom 862k citations
  2. 2 Christopher J L Murray United States 583k citations
  3. 3 Walter Churchill Willett United States 411k citations
  4. 4 Julian P. T. Higgins United Kingdom 390k citations
  5. 5 John J.V. McMurray United Kingdom 349k citations
  6. 6 Hermann Brenner Germany 343k citations
  7. 7 Emelia J. Benjamin United States 341k citations
  8. 8 Jun Wang China 340k citations
  9. 9 Stephan Windecker Switzerland 338k citations
  10. 10 Giuseppe Remuzzi Italy 328k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Heart Failure Treatment and Management?

The most cited paper in Heart Failure Treatment and Management is "2013 ACCF/AHA Guideline for the Management of Heart Failure" (Clyde W. Yancy et al., 2013), with 12,642 citations. Next come "Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?" (11,736) and "2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure" (11,598).

Most cited papers
#PaperReleasedCitations
1 2013 ACCF/AHA Guideline for the Management of Heart Failure Clyde W. Yancy et al. · Journal of the American College of Cardiology Open access 5 Jun 2013 12,642
2 Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease? Aimun Ahmed, Tom Jorna, Sunil Bhandari · ˜The œNephron journals/Nephron journals 2016 11,736
3 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Piotr Ponikowski et al. · European Heart Journal Open access134 authors 20 May 2016 11,598
4 The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure Bertram Pitt, Faiez M. Zannad, Willem J. Remme et al. · New England Journal of Medicine Open access 2 Sep 1999 9,197
5 Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients The Heart Outcomes Prevention Evaluation Study Investigators · New England Journal of Medicine Open access 20 Jan 2000 8,696
All 98 most cited papers, with filters and sorting

Where is Heart Failure Treatment and Management research done?

The largest centres of Heart Failure Treatment and Management research in 2022-now are Beijing (China), Boston (United States), London (United Kingdom) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Plymouth and Kansas City.

Largest cities, 2022-now

  1. 1 BeijingChina 207 works
  2. 2 BostonUnited States 164 works
  3. 3 LondonUnited Kingdom 159 works
  4. 4 TokyoJapan 159 works
  5. 5 New YorkUnited States 151 works
  6. 6 MadridSpain 147 works
  7. 7 SeoulSouth Korea 112 works
  8. 8 ParisFrance 101 works
  9. 9 PhiladelphiaUnited States 100 works
  10. 10 RomeItaly 98 works

Where it is the local speciality

  1. PlymouthUS · 27.0 works62×
  2. Kansas CityUS · 35.1 works9.9×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Heart Failure Treatment and Management than the world average.

See Heart Failure Treatment and Management on the map

Where is the best place to study Heart Failure Treatment and Management?

Among universities, judged by research, Harvard University, Karolinska Institutet and University of Glasgow score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 20.52%fractional works in this field (log) →share of work in the world top 10% →University of Gronin…Karolinska InstitutetUniversity of GlasgowHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 70.417.6%4.4×152 -6.7%
2Karolinska InstitutetSweden 67.822.5%7.4×45 +6.3%
3University of GlasgowUnited Kingdom 64.621.7%5.8×41 +12.1%
4University of GroningenNetherlands 63.724.9%4.8×35 -5.1%
5University of LeicesterUnited Kingdom 62.122.5%6.5×19 +46.0%
6Université de LorraineFrance 62.033.4%2.7×11 +16.7%
7Duke UniversityUnited States 60.912.5%6.2×54 +30.2%
8National University of SingaporeSingapore 59.618.5%2.1×27 +40.0%
9Wroclaw Medical UniversityPoland 59.519.7%14.8×23 +53.8%
10University of CopenhagenDenmark 58.511.9%5.3×54 +18.4%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Heart Failure Treatment and Management, country by country

Is Heart Failure Treatment and Management research growing?

Output in 2022-2025 was 25% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Heart Failure Treatment and Management.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Heart Failure Treatment and Management as a percentage of every work published that year, 0.047% in 2024.

still counting0.025%0.050%0.075%Heart Failure Treatment and Management0.055% in 202519801990200020102020

Fractional works of Heart Failure Treatment and Management over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Heart Failure Treatment and Management9.8% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Questions people ask

Who is researching a cure for heart failure?

By volume in 2022-now, Harvard University publishes the most Heart Failure Treatment and Management research, followed by Mayo Clinic and Chinese Academy of Medical Sciences & Peking Union Medical College. By volume, the United States and China publish the most (3.5k and 1.3k works in 2022-now).

All 1,273 questions in the Question Catalogue

Discussion

Ask a question or share a note about Heart Failure Treatment and Management. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.